Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shanghai Minhang Central Hospital
With
Wu Jieping Medical Foundation
Shanghai Municipal Commission of Health and Family Planning
Researchers plan to develop a diagnostic and prognostic evaluation model for prostate cancer by analyzing abnormal echoes in prostate ultrasound images through radiomics. This model will be used to guide ultrasound radiomics-fusion prostate biopsy, and its accuracy will be compared with that of systematic biopsy.
Age
55–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
1. Age ≥55 years old.
2. Patients had tPSA/fPSA within 1 month before biopsy.
3. Patients had any of the following indications for prostate biopsy:
* Suspicious prostate nodules were found by digital rectal examination
* Suspicious lesions were detected by B-ultrasound or MRI
* PSA\>10ng/ml
* PSA 4-10ng/ml, with abnormal f/tPSA and/or PSAD values
You may not be if
1. malignant tumors other than prostate adenocarcinoma indicated by pathology.
2. Combined with other malignant tumors (such as rectal cancer, bladder cancer, testicular cancer, etc.) that may affect the imaging findings of transrectal ultrasound or mpMRI.
3. Other conditions that would preclude needle biopsy: cachexia, decompensation of organ function, hemorrhagic diseases, local infection, etc
Clareo Health | Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
